CAS: 1004757-96-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide REF: 3D-EQB75796CAS: 1004757-96-3 | Min. 95% | A consultar | Vie 28 Jun 24 |
![N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide](https://static.cymitquimica.com/products/3D/thumb/EQB75796.jpg)
N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide
CAS:1004757-96-3
N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide (NAPQI) is a new drug that is being developed for the treatment of autoimmune …
Fórmula:
C25H33F3N6O2
Pureza:
Min. 95%
Peso molecular:
506.6 g/mol
Ref: 3D-EQB75796
| 100mg | A consultar | |
| 250mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 28 de Junio de 2024
